Skip to main content

Table 1 Baseline characteristics according to the liver fibrosis status staged by APRI

From: Association between liver fibrosis and thrombotic or bleeding events in acute coronary syndrome patients

Liver fibrosis

Low

Intermediate

High

p Value

Clinical characteristics

Age

58.7 (10.3)

57.6 (10.6)

58.1 (10.7)

0.028

Male

4235 (75.1)

542 (82.6)

70 (76.9)

< 0.001

BMI

25.9 (3.3)

25.7 (3.2)

26.1 (2.6)

0.29

Diabetes mellitus

1700 (30.1)

176 (26.8)

22 (24.2)

0.108

Hypertension

3680 (65.3)

390 (59.5)

55 (60.4)

0.009

Hyperlipidemia

3800 (67.4)

409 (62.3)

56 (61.5)

0.019

Smoking

3267 (57.9)

407 (62.0)

52 (57.1)

0.127

Prior PCI

1310 (23.2)

161 (24.5)

30 (33.0)

0.076

Prior CABG

225 (4.0)

24 (3.7)

4 (4.4)

0.898

Prior MI

772 (13.7)

84 (12.8)

9 (9.9)

0.485

Prior cerebrovascular disease

635 (11.3)

74 (11.3)

10 (11.0)

0.997

Peripheral vascular disease

154 (2.7)

18 (2.7)

2 (2.2)

0.953

STEMI

1139 (20.2)

277 (42.2)

58 (63.7)

< 0.001

NSTEMI

357 (6.3)

84 (12.8)

8 (8.8)

< 0.001

UA

4143 (73.5)

295 (45.0)

25 (27.5)

< 0.001

Left ventricular dysfunction

269 (4.8)

51 (7.8)

19 (20.9)

< 0.001

Renal insufficiency

2 (0.0)

2 (0.3)

0 (0.0)

0.032

Procedural characteristics

Chronic total occlusion

396 (7.0)

24 (3.7)

2 (2.2)

0.001

Left main artery disease

333 (5.9)

37 (5.6)

5 (5.5)

0.952

Moderate to severe calcification

850 (15.1)

99 (15.1)

14 (15.4)

0.997

Lesion number

1.4 (0.7)

1.4 (0.7)

1.4 (0.7)

0.656

Lesion length

28.1 (18.8)

28.4 (17.2)

26.7 (17.1)

0.72

Minimum lesion diameter

0.4 (0.5)

0.3 (0.3)

0.2 (0.3)

< 0.001

Drug-eluting stent

5399 (95.7)

618 (94.2)

81 (89.0)

0.002

Laboratory tests

AST, IU/L

20.0 (7.4)

56.1 (25.0)

216.9 (167.1)

< 0.001

ALT, IU/L

28.5 (19.3)

71.9 (55.6)

134.2 (142.8)

< 0.001

Albumin, g/dL

42.6 (4.2)

41.9 (4.7)

40.7 (4.2)

< 0.001

Total bilirubin, μmol/L

14.4 (5.4)

15.7 (6.9)

19.4 (10.5)

< 0.001

Triglycerides, mmol/L

1.8 (1.1)

1.8 (1.1)

1.8 (0.8)

0.499

Total cholesterol, mmol/L

4.2 (1.1)

4.2 (1.0)

4.5 (0.8)

0.043

LDL-C, mmol/L

2.5 (0.9)

2.5 (0.9)

2.7 (0.8)

0.075

HDL-C, mmol/L

1.0 (0.3)

1.0 (0.3)

1.1 (0.3)

0.04

Blood glucose, mmol/L

6.3 (2.3)

6.8 (3.0)

8.2 (4.5)

< 0.001

High-sensitivity C-reactive protein, mg/L

3.4 (3.9)

5.3 (5.0)

8.7 (5.8)

< 0.001

  1. Variables are shown as mean (SD) or n (%). BMI, body mass index; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; MI, myocardial infarction; STEMI, ST-segment elevation myocardial infarction; NSTEMI, non-ST-segment elevation myocardial infarction UA, unstable angina; ALT, alanine aminotransferase; AST, aspartate aminotransferase; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol